Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread
- 1 September 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 147 (3) , 621-623
- https://doi.org/10.1046/j.1365-2133.2002.488811.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trialJournal of the American Academy of Dermatology, 2001
- Imiquimod 5% cream in the treatment of Bowen's diseaseJournal of the American Academy of Dermatology, 2001
- Imiquimod: a novel treatment for lentigo malignaBritish Journal of Dermatology, 2000
- Topical imiquimod treatment of a cutaneous melanoma metastasisJournal of the American Academy of Dermatology, 2000
- Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.Journal of Investigative Dermatology, 2000
- Self-administered Topical 5% Imiquimod Cream for External Anogenital WartsArchives of Dermatology, 1998
- Cytokine induction by the immunomodulators imiquimod and S-27609Journal of Leukocyte Biology, 1995
- Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infectionAntiviral Research, 1988